Backed by top VCs including Uncork Capital, Khosla Ventures, and Y-Combinator, Menten AI is building generative AI to design next-generation macrocyclic therapeutics for challenging drug targets. It's the first platform capable of designing potent and membrane-permeable macrocycles in a matter of days. The team has demonstrated the robustness of their platform for complex drug targets including protein-protein interfaces and intracellular targets and has partnerships with top-10 pharma to accelerate their preclinical drug discovery efforts.